Future Prospects of Immunotherapy in Non-Small-Cell Lung Cancer Patients: Is There Hope in Other Immune Checkpoints Targeting Molecules?

Future Prospects of Immunotherapy in Non-Small-Cell Lung Cancer Patients: Is There Hope in Other Immune Checkpoints Targeting Molecules?

Currently, one of the leading treatments for non-small-cell lung cancer is immunotherapy involving immune checkpoint inhibitors. These monoclonal antibodies restore the anti-tumour immune response altered by negative immune checkpoint interactions. The most commonly used immunotherapeutics in monoth...

Full description

Bibliographic Details
Main Authors: Natalia Krzyżanowska, Kamila Wojas-Krawczyk, Janusz Milanowski, Paweł Krawczyk
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:International Journal of Molecular Sciences
Subjects:
non-small cell lung cancer
immunotherapy
immune checkpoints
immune checkpoint inhibitors
immune checkpoint agonists
Online Access:https://www.mdpi.com/1422-0067/23/6/3087

Internet

https://www.mdpi.com/1422-0067/23/6/3087

Similar Items